Optimising medication management in children and young people with Attention deficit hyperactivity disorder (ADHD) using an objective measure of attention, impulsivity and activity (QbTest): a feasibility study

ottinghamshire Healthcare NHS Foundation Trust0 个研究点目标入组 60 人开始时间: 2018年4月10日最近更新: 2022年8月5日

适应症

试验速览

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29453304 protocol 2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31215440 developing the protocol (added 21/06/2019) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33726855/ (added 28/06/2022)

•1. Age 6-17 years (may turn 18 during the study)
•2. Confirmed clinical diagnosis of ADHD
•3. Joint clinician/parent/young person decision to start stimulant medication for ADHD or review effectiveness of medication in CAMHS or Community Paediatric services
•4. Capable of providing written consent
•5. Parental consent (under 16 years)

•1. Unable to give informed consent
•2. Severe learning difficulty
•3. Not started on a stimulant medication (e.g. non-stimulant medication is prescribed or the family choose not to start medication at all)
•4. Non-fluent English

发起方

ottinghamshire Healthcare NHS Foundation Trust